ResMed Inc. (RMD) News

ResMed Inc. (RMD): $230.58

2.40 (-1.03%)

POWR Rating

Component Grades

Momentum

C

Stability

C

Sentiment

Quality

B

Filter RMD News Items

RMD News Results

Date Symbol Company Title Start End Change POWR Rating
Loading, please wait...

RMD News Highlights

  • 404 Page not found

    Error: Page not found

    The requested URL was not found on this server.

  • 404 Page not found

    Error: Page not found

    The requested URL was not found on this server.

  • 404 Page not found

    Error: Page not found

    The requested URL was not found on this server.

Latest RMD News From Around the Web

Below are the latest news stories about RESMED INC that investors may wish to consider to help them evaluate RMD as an investment opportunity.

Is There An Opportunity With ResMed Inc.'s (NYSE:RMD) 31% Undervaluation?

Key Insights Using the 2 Stage Free Cash Flow to Equity, ResMed fair value estimate is US$338 ResMed is estimated to be...

Yahoo | January 11, 2025

GMED Stock Rides on NuVasive Synergy Benefits Amid Macro Issues

Globus Medical is seeing notable gains across its product portfolio in expandables, biologics, MIS screws, 3D printed implants and cervical offerings.

Yahoo | January 10, 2025

How to Boost Your Portfolio with Top Medical Stocks Set to Beat Earnings

Why investors should use the Zacks Earnings ESP tool to help find stocks that are poised to top quarterly earnings estimates.

Yahoo | January 10, 2025

Here's Why You Should Retain HealthEquity Stock in Your Portfolio Now

HQY's sustained strength in HSAs raises optimism about the stock.

Yahoo | January 10, 2025

Reasons to Retain The Cooper Companies Stock in Your Portfolio Now

COO benefits from strength in its business segments. Its acquisitions are likely to drive the top line. However, a rise in selling, general and administrative expenses is concerning.

Yahoo | January 10, 2025

MYGN Stock Gains Following Collaboration With Hannah Storm

Myriad Genetics enters into an agreement with Hannah Storm, who will be the Myriad Genetics Breast Cancer Risk Assessment Program ambassador.

Yahoo | January 10, 2025

ResMed to Report Second Quarter Fiscal 2025 Earnings on January 30, 2025

SAN DIEGO, Jan. 09, 2025 (GLOBE NEWSWIRE) -- ResMed (NYSE: RMD, ASX: RMD) today announced it plans to release financial and operational results for the second quarter of fiscal year 2025 on Thursday, January 30, 2025, after the New York Stock Exchange closes. Following the release, ResMed management will host a webcast to discuss the results. Other forward-looking and material information may also be discussed during the webcast. Earnings webcast details: • Location:https://investor.resmed.com•

Yahoo | January 9, 2025

3 S&P 500 Earnings Growth Stocks to Buy in 2025: CMG, RMD, NOW

Chipotle Mexican Grill, Ulta Beauty and ServiceNow are currently exhibiting superb earnings growth.

Yahoo | January 9, 2025

Expanding Global Network, Vaccine Sales Support PAHC Stock

Phibro Animal Health is focusing on new developments along with incremental registrations and growing volumes of existing vaccine technologies.

Yahoo | January 9, 2025

BSX Stock Rises Following Bolt Medical Acquisition Deal Announcement

Boston Scientific inks a new agreement to acquire Bolt Medical, developer of Bolt IVL, for approximately $443 million.

Yahoo | January 9, 2025


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!